Truist Remains Bullish on Zymeworks (ZYME) - Here's Why
Zymeworks Inc. (NASDAQ:ZYME) is one of the best small cap stocks to buy with the highest upside potential. Truist lifted the price target on Zymeworks Inc.
Zymeworks Inc. (ZYME)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | EcoR1 Capital Oleg Nodelman | 22,970,388 | $600,445,942 | 29.19% | |
| 2. | Rubric Capital Management David Rosen | 7,000,000 | $182,980,000 | 1.68% | |
| 3. | Perceptive Advisors Joseph Edelman | 4,182,953 | $109,342,391 | +20% | 1.64% |
| 4. | Biotechnology Value Fund / BVF Inc Mark Lampert | 3,649,142 | $95,388,572 | -3% | 2.44% |
| 5. | Citadel Investment Group Ken Griffin | 914,136 | $23,895,516 | -21% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.78 | 5,919 | $69,738.25 | 17,883,908 | 2025-05-19 | Filing | |
| $11.43 | 49,502 | $565,847.46 | 17,877,989 | 2025-05-15 | Filing | |
| $11.52 | 54,760 | $630,818.77 | 17,828,487 | 2025-04-17 | Filing | |
| $11.16 | 73,953 | $825,589.11 | 17,773,727 | 2025-04-16 | Filing | |
| $11.17 | 196,438 | $2,193,799.94 | 17,699,774 | 2025-04-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $22.67 | 6,120 | $138,761.82 | 132,913 | 2026-01-12 | Filing | |
| $22.67 | 9,310 | $211,090.29 | 26,708 | 2026-01-12 | Filing | |
| $22.67 | 9,560 | $216,758.66 | 48,497 | 2026-01-12 | Filing | |
| $22.67 | 30,424 | $689,818.56 | 226,842 | 2026-01-12 | Filing | |
| $25.10 | 10,538 | $264,471.13 | 18,352 | 2026-01-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,251,030 | $111,121,925 | 0% | |
| 2. | 2,231,260 | $58,325,141 | 0% | |
| 3. | 1,781,116 | $46,558,373 | 0.05% | |
| 4. | 1,558,998 | $40,752,208 | 0% | |
| 5. | 1,252,027 | $32,727,986 | 0.04% |
News See All
10 Best Small Cap Stocks to Buy with Highest Upside Potential
On July 6, Tom Lee, Fundstrat managing partner, appeared on CNBC’s ‘Squawk Box’ to talk about the latest market trends, his expectations for the S&P 500 this year, and more.
Is Zymeworks Inc. (ZYME) Stock an Undervalued Biotech Opportunity With Oncology Growth Ahead?
TheFly reported on June 9 that Truist Securities initiated coverage of ZYME with a Buy rating and a $28 price target, down from $40.
10 Best Biotech Stocks to Buy According to Analysts
Biotechnology is enjoying one of its strongest years in recent times, which is mostly fueled by a rebound in capital markets, rising merger activity, and renewed investor confidence.
Zymeworks Inc. (NASDAQ:ZYME) Q1 2026 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to Zymeworks Inc. First Quarter 2026 Results Conference Call. At this time, all participants are in a listen-only mode.
Zymeworks Inc. (NASDAQ:ZYME) Q4 2025 Earnings Call Transcript
Operator: Thank you for standing by. This is the conference operator. Welcome to the Zymeworks Inc. Fourth Quarter 2025 Results Conference Call and Webcast.
Zymeworks Inc. (NASDAQ:ZYME) Q3 2025 Earnings Call Transcript
Shrinal Inamdar: Thank you, operator. Good afternoon, everyone. Thank you for joining our third quarter 2025 results conference call.
Zymeworks Inc. (NASDAQ:ZYME) Q2 2025 Earnings Call Transcript
Operator: Thank you for standing by. This is the conference operator. Welcome to Zymeworks Second Quarter 2025 Results Conference Call and Webcast.
Zymeworks Inc. (NYSE:ZYME) Q1 2025 Earnings Call Transcript
Operator: Thank you for standing by. This is the conference operator. Welcome to Zymeworks First Quarter 2025 Results Conference Call and Webcast.
Zymeworks Inc. (NYSE:ZYME) Q4 2024 Earnings Call Transcript
Operator: Thank you for standing by. This is the conference operator. Welcome to Zymeworks Fourth Quarter and Year-end 2024 Results Conference Call and Webcast.
Hedge Fund Resource Center